These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 21211377)

  • 1. [Devote much attention to improve quality of life of benign prostatic hypertrophy patients with overactive bladder symptoms].
    Liao LM; Na YQ
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1761-2. PubMed ID: 21211377
    [No Abstract]   [Full Text] [Related]  

  • 2. [The urodynamic diagnosis of benign prostatic hyperplasia with coexisting overactive bladder].
    Chen Y; DU GH; Chen Z; Cai D; Zhang Q; Yuan XY; Zeng XY; Yang WM; Ye ZQ
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1767-70. PubMed ID: 21211379
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Clinical observation of holmium laser enucleation of the prostate in the treatment of benign prostatic hyperplasia and overactive bladder].
    Fu G; Liao LM; Hu Y; Li D; Ju YH; Wu J; Liang WL; Xiong ZS
    Zhonghua Wai Ke Za Zhi; 2010 Dec; 48(23):1774-7. PubMed ID: 21211381
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lower urinary tract symptoms (LUTS) in men: thinking beyond the prostate.
    Elsamra S; Ellsworth PS
    Med Health R I; 2010 Feb; 93(2):53-6. PubMed ID: 20329627
    [No Abstract]   [Full Text] [Related]  

  • 5. [Effectiveness and safety of naftopidil for benign prostatic hyperplasia patients with overactive bladder symptoms].
    Ge JP; Gong J; Ma HQ; Wei W; Shang XJ; Zhang ZY; Xu S; Wang D; Gao JP
    Zhonghua Nan Ke Xue; 2008 Oct; 14(10):927-30. PubMed ID: 19157107
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Combined treatment of patients with prostatic adenoma and overactive bladder].
    Maksimov VA; Khodyreva LA; Dudareva AA; Al'bitskaia AIu
    Urologiia; 2011; (6):46, 48-50. PubMed ID: 22448481
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Extended-release tolterodine with or without tamsulosin in men with lower urinary tract symptoms and overactive bladder: effects on urinary symptoms assessed by the International Prostate Symptom Score.
    Kaplan SA; Roehrborn CG; Chancellor M; Carlsson M; Bavendam T; Guan Z
    BJU Int; 2008 Nov; 102(9):1133-9. PubMed ID: 18510659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Naftopidil and propiverine hydrochloride for treatment of male lower urinary tract symptoms suggestive of benign prostatic hyperplasia and concomitant overactive bladder: a prospective randomized controlled study.
    Yokoyama T; Uematsu K; Watanabe T; Sasaki K; Kumon H; Nagai A;
    Scand J Urol Nephrol; 2009; 43(4):307-14. PubMed ID: 19396723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Management of benign prostatic hypertrophy-related urinary retention: current trends and perspectives.
    Stamatiou K
    Urol J; 2009; 6(4):237-44. PubMed ID: 20027550
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The profiles and patterns of detrusor overactivity and their association with overactive bladder symptoms in men with benign prostatic enlargement associated with detrusor overactivity.
    Shahab N; Seki N; Takahashi R; Kajioka S; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2009; 28(8):953-8. PubMed ID: 19260093
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The pathophysiology underlying overactive bladder syndrome possibly due to benign prostatic hyperplasia].
    Akino H; Maegawa M; Nagase K; Tanaka I; Nakai M; Ishida Y; Oyama N; Miwa Y; Yokoyama O
    Hinyokika Kiyo; 2008 Jun; 54(6):449-52. PubMed ID: 18634444
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Defining the role of overactive bladder treatments in men with lower urinary tract symptoms.
    Lemack GE
    Nat Clin Pract Urol; 2007 Apr; 4(4):174-5. PubMed ID: 17415351
    [No Abstract]   [Full Text] [Related]  

  • 13. Nocturia: a non-specific but important symptom of urological disease.
    Schneider T; de la Rosette JJ; Michel MC
    Int J Urol; 2009 Mar; 16(3):249-56. PubMed ID: 19226359
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Botulinum toxin for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia.
    Antunes AA; Srougi M; Coelho RF; de Campos Freire G
    Nat Clin Pract Urol; 2007 Mar; 4(3):155-60. PubMed ID: 17347660
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A role of intravesical capsaicin instillation in benign prostatic hyperplasia with overactive bladder symptoms: the first reported study in the literature.
    Mahawong P; Chaiyaprasithi B; Soontrapa S; Tappayuthapijarn P
    J Med Assoc Thai; 2007 Nov; 90(11):2301-9. PubMed ID: 18181311
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Interrelation of hyperactivity of bladder and infravesical obstruction in patients with benign prostate hyperplasia].
    Bablumyan A
    Georgian Med News; 2010 Dec; (189):7-11. PubMed ID: 21252402
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A role of intravesical capsaicin instillation in benign prostatic hyperplasia with overactive bladder symptoms: the first reported study in the literature.
    Mahawong P; Chaiyaprasithi B; Soontrapa S; Tappayuthapijarn P
    J Med Assoc Thai; 2007 Sep; 90(9):1821-7. PubMed ID: 17957925
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association among the symptoms, quality of life and urodynamic parameters in patients with improved lower urinary tract symptoms following a transurethral resection of the prostate.
    Seki N; Yunoki T; Tomoda T; Takei M; Yamaguchi A; Naito S
    Neurourol Urodyn; 2008; 27(3):222-5. PubMed ID: 17580358
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Efficacy of naftopidil in patients with overactive bladder associated with benign prostatic hyperplasia: prospective randomized controlled study to compare differences in efficacy between morning and evening medication].
    Sakai H; Igawa T; Onita T; Furukawa M; Hakariya T; Hayashi M; Matsuya F; Shida Y; Nishimura N; Yogi Y; Tsurusaki T; Takehara K; Nomata K; Shiraishi K; Shono T; Aoki D; Kanetake H
    Hinyokika Kiyo; 2011 Jan; 57(1):7-13. PubMed ID: 21304253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential diagnosis of overactive bladder in men.
    Blaivas JG; Marks BK; Weiss JP; Panagopoulos G; Somaroo C
    J Urol; 2009 Dec; 182(6):2814-7. PubMed ID: 19837417
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.